Literature DB >> 22459389

CRP and suPAR are differently related to anthropometry and subclinical organ damage.

Stig Lyngbæk1, Thomas Sehestedt, Jacob L Marott, Tine W Hansen, Michael H Olsen, Ove Andersen, Allan Linneberg, Sten Madsbad, Steen B Haugaard, Jesper Eugen-Olsen, Jørgen Jeppesen.   

Abstract

BACKGROUND: Low-grade inflammation is a marker for cardiovascular disease (CVD). The inflammatory biomarkers C-reactive protein (CRP) and soluble urokinase plasminogen activator receptor (suPAR) independently predict CVD. We tested the hypothesis that these biomarkers reflect different aspects of the inflammation associated with CVD.
METHODS: We studied 2273 subjects without CVD. Log-transformed CRP and suPAR were included in general linear and logistic regression models to compare associations with measures of anthropometry and subclinical organ damage (SOD). Owing to interactions on body mass index (BMI) (P<0.0001), the population was stratified by gender and smoking concerning anthropometry.
RESULTS: In both genders, independent of smoking, log-CRP was positively associated with BMI (β: 0.28 to 0.40, P<0.001) and waist circumference (WC) (β: 0.27 to 0.42, P<0.001). In contrast, in smoking women and men, log-suPAR was negatively associated with BMI and WC (β: -0.09 to -0.19, P<0.05). In non-smoking women, log-suPAR was positively associated with BMI and WC (β: 0.14 and 0.16, P<0.001), whereas no associations were found in non-smoking men. No interactions were found on SOD. Adjusted for age, sex, smoking, and physical activity, log-suPAR was associated with an increased urine albumin/creatinine ratio (standardized odds ratio (95% confidence interval (CI)) for highest vs. lower quartiles: 1.36 (1.21-1.52), whereas log-CRP was not (1.10 (0.99-1.22))), and extent of atherosclerosis (standardized proportional odds ratio (95% CI) for carotid plaques 0, 1 ≤ to ≤ 3, >3: 1.31 (1.16-1.47), whereas log-CRP was not (1.00 (0.89-1.11))).
CONCLUSIONS: CRP is positively associated with anthropometric measures, whereas suPAR is linked to endothelial dysfunction and atherosclerosis.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Anthropometry; C-reactive protein; Cardiovascular biomarkers; Obesity; Soluble urokinase plasminogen activator receptor; Subclinical organ damage

Mesh:

Substances:

Year:  2012        PMID: 22459389     DOI: 10.1016/j.ijcard.2012.03.040

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  43 in total

1.  Reproducibility of novel immune-inflammatory biomarkers over 4 months: an analysis with repeated measures design.

Authors:  Matthew Schenk; Fabian Eichelmann; Matthias B Schulze; Natalia Rudovich; Andreas F Pfeiffer; Romina di Giuseppe; Heiner Boeing; Krasimira Aleksandrova
Journal:  Biomark Med       Date:  2019-06-03       Impact factor: 2.851

2.  Impact of lifestyle intervention for obese women during pregnancy on maternal metabolic and inflammatory markers.

Authors:  K M Renault; E M Carlsen; S Hædersdal; L Nilas; N J Secher; J Eugen-Olsen; D Cortes; S F Olsen; T I Halldorsson; K Nørgaard
Journal:  Int J Obes (Lond)       Date:  2017-01-17       Impact factor: 5.095

3.  Soluble urokinase plasminogen activator receptor and hypertension among black South Africans after 5 years.

Authors:  Shani Botha; Carla Mt Fourie; Rudolph Schutte; Jesper Eugen-Olsen; Aletta E Schutte
Journal:  Hypertens Res       Date:  2015-03-05       Impact factor: 3.872

4.  Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Predictor of Incident Atrial Fibrillation.

Authors:  Oscar Westin; Line Jee Hartmann Rasmussen; Ove Andersen; Eric Buch; Jesper Eugen- Olsen; Jens Friberg
Journal:  J Atr Fibrillation       Date:  2018-04-30

5.  Association between suPAR and cardiac diastolic dysfunction among patients with preserved ejection fraction.

Authors:  Tomohiro Fujisaka; Shu-Ichi Fujita; Daichi Maeda; Kensaku Shibata; Hideaki Takahashi; Hideaki Morita; Yoshihiro Takeda; Takahide Ito; Koichi Sohmiya; Masaaki Hoshiga; Nobukazu Ishizaka
Journal:  Heart Vessels       Date:  2017-06-06       Impact factor: 2.037

6.  The pro-inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) is associated with incident type 2 diabetes among overweight but not obese individuals with impaired glucose regulation: effect modification by smoking and body weight status.

Authors:  A Heraclides; T M Jensen; S S Rasmussen; J Eugen-Olsen; S B Haugaard; K Borch-Johnsen; A Sandbæk; T Lauritzen; D R Witte
Journal:  Diabetologia       Date:  2013-04-24       Impact factor: 10.122

7.  Circulating suPAR in two cohorts of primary FSGS.

Authors:  Changli Wei; Howard Trachtman; Jing Li; Chuanhui Dong; Aaron L Friedman; Jennifer J Gassman; June L McMahan; Milena Radeva; Karsten M Heil; Agnes Trautmann; Ali Anarat; Sevinc Emre; Gian M Ghiggeri; Fatih Ozaltin; Dieter Haffner; Debbie S Gipson; Frederick Kaskel; Dagmar-Christiane Fischer; Franz Schaefer; Jochen Reiser
Journal:  J Am Soc Nephrol       Date:  2012-11-08       Impact factor: 10.121

8.  Cumulative childhood risk is associated with a new measure of chronic inflammation in adulthood.

Authors:  Line Jee Hartmann Rasmussen; Terrie E Moffitt; Jesper Eugen-Olsen; Daniel W Belsky; Andrea Danese; HonaLee Harrington; Renate M Houts; Richie Poulton; Karen Sugden; Benjamin Williams; Avshalom Caspi
Journal:  J Child Psychol Psychiatry       Date:  2018-05-09       Impact factor: 8.982

9.  Activation of the acute inflammatory phase response in idiopathic nephrotic syndrome: association with clinicopathological phenotypes and with response to corticosteroids.

Authors:  Neus Roca; Cristina Martinez; Elias Jatem; Alvaro Madrid; Mercedes Lopez; Alfons Segarra
Journal:  Clin Kidney J       Date:  2021-03-30

10.  Vascular Structure and Inflammation in a South African Population: The SABPA Study.

Authors:  Carla Swart; Leandi Lammertyn; Paul I Welsh; Shani Botha-Le Roux
Journal:  Pulse (Basel)       Date:  2019-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.